
Oncology NEWS International
- Oncology NEWS International Vol 15 No 6
- Volume 15
- Issue 6
Outside Consultant Will Evaluate FDA's Postmarketing Studies Practices
The FDA has awarded a $1.09 million contract for an evaluation of the agency's process of establishing postmarketing, or phase IV, studies. The consulting firm of Booz Allen Hamilton will conduct the 1-year evaluation and make recommendations to the agency for improving and standardizing the process.
ROCKVILLE, MarylandThe FDA has awarded a $1.09 million contract for an evaluation of the agency's process of establishing postmarketing, or phase IV, studies. The consulting firm of Booz Allen Hamilton will conduct the 1-year evaluation and make recommendations to the agency for improving and standardizing the process.
Articles in this issue
about 20 years ago
Triple-Negative Cancers More Common in Young Black Ptsabout 20 years ago
Artists Turn Flowers & Curves Into 'Forms' and 'Figures'about 20 years ago
Study to Examine Outcomes Disparities in Pediatric ALLabout 20 years ago
Thalidomide Has 'Changed the Paradigm' in Myeloma Rxabout 20 years ago
CA4P Gets Orphan Drug Statusabout 20 years ago
Testicular Ca Survivors at Increased Risk for CV Eventsabout 20 years ago
A Novel Brings a Cancer Research Laboratory to Lifeabout 20 years ago
NCCN Reveals New Venous Thromboembolism Guidelineabout 20 years ago
Lapatinib New Option for Metastatic HER2+ Breast Caabout 20 years ago
FDA Approves Dacogen for Treating All MDS Subtypes











































































